Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

ExoTherapy offers hope for treating acute spinal cord injuries

Suffering from traumatic injuries can leave a person with long-term damages and/or side effects that are hard to navigate long after the initial incident has passed. Our next company is a publicly traded bio-pharmaceutical company, working on the development of its ...
Brieanna McCutcheon | September 19, 2023 |

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...
Research | 10 days ago |

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...
Knox Henderson | July 2, 2024 |

Cracking the Code to Society’s Most Feared Disease

Even more so than cancer, it’s the one disease that we all fear the most. The thought of falling prey to Alzheimer’s disease and to the inevitable desecration of our mind is something that makes even the bravest among us shudder. ...
Marc Davis | February 7, 2020 |

The Golden Question

Call it a dream, stupidity or mere eventuality but a year or two ago when gold was hovering between US$1150/ounce and US$1200/ounce, I spoke about my prediction that gold may hit $2000 US/ounce within a few short years. At this year’s PDAC conference, during...
Dr. Kal Kotecha | September 18, 2019 |

Tax loss selling…is it a good time for investors?

Every year on Black Friday, shoppers anticipate great deals and are lined out the door to get a discount on a TV or on a much needed appliance. Buyers will go to many lengths, including camping outside the store to be the first in or even trampling on other shoppers to get t...
Dr. Kal Kotecha | December 11, 2019 |

Are We There Yet?

Gold is trading around US$1600/ounce. In my interviews that were done between 2017-2019, I was asked about the prospects of gold. I stated that I believed between 2020-2021 we’d see gold above $2000 + ounce. We are getting closer. This bodes extremely well fo...
Dr. Kal Kotecha | February 7, 2020 |

PDAC 2020

PDAC 2020 will be taking place during March 1 st -March 4 th at the Toronto Metro Convention Centre. It is the world’s premier mining and finance conference. “ The World’s Premier Mineral Exploration & Mining Convention is the leading convent...
Dr. Kal Kotecha | February 27, 2020 |

JOIN ME FOR MY TALK AT PDAC 2020

I have the honour of speaking again at PDAC this Sunday March 1st. As you know, it has been a tumultuous week for the overall stock markets including gold stocks. I will be covering that and many other pertinent topics in my talk. I will be speaking at 3:45PM. Following my t...
Dr. Kal Kotecha | February 28, 2020 |

Leading logistics company emphasizes risk mitigation

Our next company is Mullen Group Ltd. (TSX:MTL) , one of North America’s largest logistics providers, housing a network of independently operated businesses. We spoke with Randy Mercer, Director of Risk Management, who detailed the compa...
Brieanna McCutcheon | March 8, 2024 |
1 2 3 4 5